Joachim Schwäble

3.6k total citations
33 papers, 2.1k citations indexed

About

Joachim Schwäble is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Joachim Schwäble has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Hematology and 9 papers in Oncology. Recurrent topics in Joachim Schwäble's work include Acute Myeloid Leukemia Research (14 papers), Protein Degradation and Inhibitors (6 papers) and Virus-based gene therapy research (4 papers). Joachim Schwäble is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Protein Degradation and Inhibitors (6 papers) and Virus-based gene therapy research (4 papers). Joachim Schwäble collaborates with scholars based in Germany, United States and United Kingdom. Joachim Schwäble's co-authors include Hubert Serve, Carsten Müller‐Tidow, Wolfgang E. Berdel, Bülent Sargin, Chunaram Choudhary, Christian Brandts, Lara Tickenbrock, Björn Steffen, Manuel Grez and Janine Reichenbach and has published in prestigious journals such as Blood, Cancer Research and Analytical Biochemistry.

In The Last Decade

Joachim Schwäble

32 papers receiving 2.1k citations

Peers

Joachim Schwäble
Luke F. Peterson United States
S. Tiong Ong United States
Douglas Tkachuk United States
Paul M. Ayton United States
Marc A. Kerenyi United States
SJ Sharkis United States
Christopher J. Ott United States
Joachim Schwäble
Citations per year, relative to Joachim Schwäble Joachim Schwäble (= 1×) peers Donatella Venturelli

Countries citing papers authored by Joachim Schwäble

Since Specialization
Citations

This map shows the geographic impact of Joachim Schwäble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Schwäble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Schwäble more than expected).

Fields of papers citing papers by Joachim Schwäble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Schwäble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Schwäble. The network helps show where Joachim Schwäble may publish in the future.

Co-authorship network of co-authors of Joachim Schwäble

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Schwäble. A scholar is included among the top collaborators of Joachim Schwäble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Schwäble. Joachim Schwäble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Epah, Jeremy, Gabriele Spohn, Markus Müller, et al.. (2023). Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss. BMC Medicine. 21(1). 360–360. 2 indexed citations
3.
Leiblein, Maximilian, Alexander Schaible, Maren Janko, et al.. (2020). First Human Leucocyte Antigen (HLA) Response and Safety Evaluation of Fibrous Demineralized Bone Matrix in a Critical Size Femoral Defect Model of the Sprague-Dawley Rat. Materials. 13(14). 3120–3120. 6 indexed citations
4.
Miesbach, Wolfgang, Joachim Schwäble, Markus Müller, & Erhard Seifried. (2019). Treatment Options in Hemophilia. Deutsches Ärzteblatt international. 116(47). 791–798. 15 indexed citations
5.
Sürün, Duran, Joachim Schwäble, Ana Tomasovic, et al.. (2017). High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing. Molecular Therapy — Nucleic Acids. 10. 1–8. 33 indexed citations
6.
Stein, Stefan, Linping Chen-Wichmann, Fabien Touzot, et al.. (2016). Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions. Journal of Allergy and Clinical Immunology. 138(1). 219–228.e9. 55 indexed citations
7.
Brendel, Christian, Daniela Abriss, Martijn H. Brugman, et al.. (2014). CD133-targeted Gene Transfer Into Long-term Repopulating Hematopoietic Stem Cells. Molecular Therapy. 23(1). 63–70. 22 indexed citations
8.
Kaufmann, Kerstin B., Christian Brendel, Julia D. Suerth, et al.. (2012). Alpharetroviral Vector-mediated Gene Therapy for X-CGD: Functional Correction and Lack of Aberrant Splicing. Molecular Therapy. 21(3). 648–661. 25 indexed citations
9.
Grez, Manuel, Janine Reichenbach, Joachim Schwäble, et al.. (2010). Gene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma. Molecular Therapy. 19(1). 28–35. 108 indexed citations
10.
Choudhary, Chunaram, Christian Brandts, Joachim Schwäble, et al.. (2006). Activation Mechanisms of STAT5 by Oncogenic Flt3-ITD.. Blood. 108(11). 1435–1435. 4 indexed citations
11.
Steffen, Björn, Carsten Müller‐Tidow, Joachim Schwäble, Wolfgang E. Berdel, & Hubert Serve. (2005). The molecular pathogenesis of acute myeloid leukemia. Critical Reviews in Oncology/Hematology. 56(2). 195–221. 60 indexed citations
12.
Tickenbrock, Lara, Joachim Schwäble, Björn Steffen, et al.. (2005). Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction. Blood. 105(9). 3699–3706. 92 indexed citations
13.
Müller‐Tidow, Carsten, Horst Buerger, Jens Packeisen, et al.. (2004). Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia. Leukemia. 18(4). 720–726. 24 indexed citations
14.
Worch, Jennifer, Lara Tickenbrock, Joachim Schwäble, et al.. (2004). The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARα and regulates differentiation of hematopoietic cells. Oncogene. 23(57). 9162–9172. 24 indexed citations
15.
Schmidt‐Arras, Dirk, et al.. (2004). Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia. Current Pharmaceutical Design. 10(16). 1867–1883. 57 indexed citations
16.
Mizuki, Masao, Joachim Schwäble, Chunaram Choudhary, et al.. (2003). Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood. 101(8). 3164–3173. 238 indexed citations
17.
Mizuki, Masao, Shuji Ueda, Itaru Matsumura, et al.. (2003). Oncogenic receptor tyrosine kinase in leukemia.. PubMed. 49(6). 907–22. 10 indexed citations
18.
Müller‐Tidow, Carsten, Masao Mizuki, Joachim Schwäble, et al.. (2002). Mutationen des Wachstumsfaktor-Rezeptors Flt3 bei Akuter Myeloischer Leukämie. DMW - Deutsche Medizinische Wochenschrift. 127(42). 2195–2200. 5 indexed citations
19.
Teller, Steffen, David Kramer, Donald Small, et al.. (2002). Bis(1H-2-indolyl)-1-methanones as inhibitors of the hematopoietic tyrosine kinase Flt3. Leukemia. 16(8). 1528–1534. 28 indexed citations
20.
Girgert, Rainer, P. Schweizer, & Joachim Schwäble. (2000). Neuroblastoma: Induction of Differentiation (Part I). European Journal of Pediatric Surgery. 10(2). 79–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026